Tagrisso 80mg

Tagrisso 80 mg was approved by the Japanese Ministry of Health, Labor and Welfare MHLW in the treatment of non-small cell lung cancer with the positive status of the T790M mutation. The remedy has also been approved by European and American research centers and clinics. The remedy is intended for the effective treatment of certain metastatic lung cancer and its inoperable forms. The manufacturer of the medication is the well-known and well-proven pharmaceutical company AstraZeneca.

About the preparation

The remedy is the generic preparation LuciOsim, popular in Europe. The remedy-generic is available in tablets form 80 mg. It is a highly effective inhibitor of kinase. Round or oval tablets have the inscription “AZ”, which confirms the authenticity of the remedy. They also indicate the dosage of the remedy. The active substance of the composition of the remedy, as in the original medicine, is osimertinib. It has a powerful antitumour effect.

If you do not know what medicine to choose to fight cancer, consult your doctor about the advisability of using Tagrisso 80 mg. This medicine has already gained popularity in the fight against lung cancer. At Tagrisso 80 mg patients’ reviews are found in most cases positive. Patients note that the remedy has a pronounced antitumour effect. The remedy slows the progression of the disease and helps restore the body after therapy with tyrosine kinase inhibitors EGFR. The medicine is appointed by the attending physician only after determining the mutation.

Properties

The active substance of the remedy binds to mutant FGFR genes. As the studies showed, the generic remedy showed high efficacy against mutations of FGFR lung cancer, as well as activity against wild genes.

The generic metabolites have a high therapeutic effect and are detrimental to the T790M mutation. If you doubt the effectiveness of the remedy, you can read the medication Tagrisso 80 mg reviews on the Web. Basically, they clearly indicate the high efficacy of the remedy, but in some cases, side reactions may occur. There may be a decrease in appetite, diarrhea, rash, fatigue, nausea, headache.

How to apply Tagrisso 80 mg.

Treatment with the remedy is adjusted by the doctor. Therapy depends on the severity of the condition and the characteristics of the disease. In the treatment it is recommended to exclude the joint use of Tagrisso with CYP3A inhibitors. The remedy is incompatible with admission with such remedies as Carbamazepine, Telithromycin, Itraconazole. You cannot use tablets with St. John’s wort extract.

The remedy is recommended for use in a dosage of 80 mg per day. The using of the tablet does not depend on the intake of food. In some cases, individual correction of the dose by the attending physician is possible. With severe side effects and further progression of cancer, therapy is stopped.